A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group

P. Dillon, Harold Maurice Maurer, J. Jenkins, T. Krummel, D. Parham, B. Webber, A. Salzberg

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Nonrhabdomyosarcoma soft tissue sarcomas in infants and children are rare malignancies with most of the clinical data gained by retrospective analysis. In 1986, a prospective multicentered study was initiated by the Pediatric Oncology Group (POG) with a total of 75 cases now entered for epidemiologic examination. Median age of presentation was 12 years (range, newborn to 20 years). The male to female ratio was 2.3 to 1. The most common soft tissue tumor was synovial cell sarcoma ( 32 75, 42%), followed by fibrosarcoma ( 10 75, 13%), malignant fibrous histiocytoma ( 9 75, 12%), and malignant neurogenic tumors ( 8 75, 10%). Sixty-five percent of all tumors presented on the extremities (44% lower extremity, 21% upper extremity). Tumors of the trunk accounted for 28% (abdomen 15%, thorax 13%), whereas head and neck tumors were 7%. By TNMG classification, 16% presented as stage I, 21% as stage II, 33% as stage III, and 30% as stage IV. Age at presentation did not affect clinical site or stage. All upper extremity tumors presented with localized disease, whereas lower extremity tumors presented with regional nodal disease in 7% and metastatic disease (pulmonary) in 23% of the cases. Seventy-eight percent of the abdominal tumors were metastatic at diagnosis; the other 22% had extensive regional disease. In the thorax 78% had localized lesions with 22% having extensive regional disease. Ninety percent of synovial cell sarcomas were on the extremities: 84% localized disease and 12% metastatic spread at presentation. Sixty percent of the fibrosarcomas presented on the extremities with 80% having localized disease and 20% metastatic spread. Only 25% of the neurogenic tumors presented with localized disease, whereas 50% had metastases at the time of diagnosis. Because a significant percentage of nonrhabdomyosarcoma soft tissue tumors in the pediatric population present with regional and metastatic disease, incisional biopsy for diagnosis, surgical control of local disease, node sampling for accurate staging, and evaluation for metastatic spread remain crucial for maximizing outcome.

Original languageEnglish (US)
Pages (from-to)241-245
Number of pages5
JournalJournal of pediatric surgery
Volume27
Issue number2
DOIs
StatePublished - Jan 1 1992

Fingerprint

Sarcoma
Age Groups
Prospective Studies
Pediatrics
Neoplasms
Synovial Sarcoma
Extremities
Fibrosarcoma
Upper Extremity
Lower Extremity
Thorax
Malignant Fibrous Histiocytoma
Abdomen
Lung Diseases
Neck
Head
Newborn Infant
Neoplasm Metastasis
Biopsy

Keywords

  • Nonrhabdomyosarcoma soft tissue tumor
  • pediatric malignancies

ASJC Scopus subject areas

  • Surgery
  • Pediatrics, Perinatology, and Child Health

Cite this

Dillon, P., Maurer, H. M., Jenkins, J., Krummel, T., Parham, D., Webber, B., & Salzberg, A. (1992). A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group. Journal of pediatric surgery, 27(2), 241-245. https://doi.org/10.1016/0022-3468(92)90320-7

A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group. / Dillon, P.; Maurer, Harold Maurice; Jenkins, J.; Krummel, T.; Parham, D.; Webber, B.; Salzberg, A.

In: Journal of pediatric surgery, Vol. 27, No. 2, 01.01.1992, p. 241-245.

Research output: Contribution to journalArticle

Dillon, P, Maurer, HM, Jenkins, J, Krummel, T, Parham, D, Webber, B & Salzberg, A 1992, 'A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group', Journal of pediatric surgery, vol. 27, no. 2, pp. 241-245. https://doi.org/10.1016/0022-3468(92)90320-7
Dillon, P. ; Maurer, Harold Maurice ; Jenkins, J. ; Krummel, T. ; Parham, D. ; Webber, B. ; Salzberg, A. / A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group. In: Journal of pediatric surgery. 1992 ; Vol. 27, No. 2. pp. 241-245.
@article{ff76e51960e64c228aaa57a0d568ee98,
title = "A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group",
abstract = "Nonrhabdomyosarcoma soft tissue sarcomas in infants and children are rare malignancies with most of the clinical data gained by retrospective analysis. In 1986, a prospective multicentered study was initiated by the Pediatric Oncology Group (POG) with a total of 75 cases now entered for epidemiologic examination. Median age of presentation was 12 years (range, newborn to 20 years). The male to female ratio was 2.3 to 1. The most common soft tissue tumor was synovial cell sarcoma ( 32 75, 42{\%}), followed by fibrosarcoma ( 10 75, 13{\%}), malignant fibrous histiocytoma ( 9 75, 12{\%}), and malignant neurogenic tumors ( 8 75, 10{\%}). Sixty-five percent of all tumors presented on the extremities (44{\%} lower extremity, 21{\%} upper extremity). Tumors of the trunk accounted for 28{\%} (abdomen 15{\%}, thorax 13{\%}), whereas head and neck tumors were 7{\%}. By TNMG classification, 16{\%} presented as stage I, 21{\%} as stage II, 33{\%} as stage III, and 30{\%} as stage IV. Age at presentation did not affect clinical site or stage. All upper extremity tumors presented with localized disease, whereas lower extremity tumors presented with regional nodal disease in 7{\%} and metastatic disease (pulmonary) in 23{\%} of the cases. Seventy-eight percent of the abdominal tumors were metastatic at diagnosis; the other 22{\%} had extensive regional disease. In the thorax 78{\%} had localized lesions with 22{\%} having extensive regional disease. Ninety percent of synovial cell sarcomas were on the extremities: 84{\%} localized disease and 12{\%} metastatic spread at presentation. Sixty percent of the fibrosarcomas presented on the extremities with 80{\%} having localized disease and 20{\%} metastatic spread. Only 25{\%} of the neurogenic tumors presented with localized disease, whereas 50{\%} had metastases at the time of diagnosis. Because a significant percentage of nonrhabdomyosarcoma soft tissue tumors in the pediatric population present with regional and metastatic disease, incisional biopsy for diagnosis, surgical control of local disease, node sampling for accurate staging, and evaluation for metastatic spread remain crucial for maximizing outcome.",
keywords = "Nonrhabdomyosarcoma soft tissue tumor, pediatric malignancies",
author = "P. Dillon and Maurer, {Harold Maurice} and J. Jenkins and T. Krummel and D. Parham and B. Webber and A. Salzberg",
year = "1992",
month = "1",
day = "1",
doi = "10.1016/0022-3468(92)90320-7",
language = "English (US)",
volume = "27",
pages = "241--245",
journal = "Journal of Pediatric Surgery",
issn = "0022-3468",
publisher = "W.B. Saunders Ltd",
number = "2",

}

TY - JOUR

T1 - A prospective study of nonrhabdomyosarcoma soft tissue sarcomas in the pediatric age group

AU - Dillon, P.

AU - Maurer, Harold Maurice

AU - Jenkins, J.

AU - Krummel, T.

AU - Parham, D.

AU - Webber, B.

AU - Salzberg, A.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Nonrhabdomyosarcoma soft tissue sarcomas in infants and children are rare malignancies with most of the clinical data gained by retrospective analysis. In 1986, a prospective multicentered study was initiated by the Pediatric Oncology Group (POG) with a total of 75 cases now entered for epidemiologic examination. Median age of presentation was 12 years (range, newborn to 20 years). The male to female ratio was 2.3 to 1. The most common soft tissue tumor was synovial cell sarcoma ( 32 75, 42%), followed by fibrosarcoma ( 10 75, 13%), malignant fibrous histiocytoma ( 9 75, 12%), and malignant neurogenic tumors ( 8 75, 10%). Sixty-five percent of all tumors presented on the extremities (44% lower extremity, 21% upper extremity). Tumors of the trunk accounted for 28% (abdomen 15%, thorax 13%), whereas head and neck tumors were 7%. By TNMG classification, 16% presented as stage I, 21% as stage II, 33% as stage III, and 30% as stage IV. Age at presentation did not affect clinical site or stage. All upper extremity tumors presented with localized disease, whereas lower extremity tumors presented with regional nodal disease in 7% and metastatic disease (pulmonary) in 23% of the cases. Seventy-eight percent of the abdominal tumors were metastatic at diagnosis; the other 22% had extensive regional disease. In the thorax 78% had localized lesions with 22% having extensive regional disease. Ninety percent of synovial cell sarcomas were on the extremities: 84% localized disease and 12% metastatic spread at presentation. Sixty percent of the fibrosarcomas presented on the extremities with 80% having localized disease and 20% metastatic spread. Only 25% of the neurogenic tumors presented with localized disease, whereas 50% had metastases at the time of diagnosis. Because a significant percentage of nonrhabdomyosarcoma soft tissue tumors in the pediatric population present with regional and metastatic disease, incisional biopsy for diagnosis, surgical control of local disease, node sampling for accurate staging, and evaluation for metastatic spread remain crucial for maximizing outcome.

AB - Nonrhabdomyosarcoma soft tissue sarcomas in infants and children are rare malignancies with most of the clinical data gained by retrospective analysis. In 1986, a prospective multicentered study was initiated by the Pediatric Oncology Group (POG) with a total of 75 cases now entered for epidemiologic examination. Median age of presentation was 12 years (range, newborn to 20 years). The male to female ratio was 2.3 to 1. The most common soft tissue tumor was synovial cell sarcoma ( 32 75, 42%), followed by fibrosarcoma ( 10 75, 13%), malignant fibrous histiocytoma ( 9 75, 12%), and malignant neurogenic tumors ( 8 75, 10%). Sixty-five percent of all tumors presented on the extremities (44% lower extremity, 21% upper extremity). Tumors of the trunk accounted for 28% (abdomen 15%, thorax 13%), whereas head and neck tumors were 7%. By TNMG classification, 16% presented as stage I, 21% as stage II, 33% as stage III, and 30% as stage IV. Age at presentation did not affect clinical site or stage. All upper extremity tumors presented with localized disease, whereas lower extremity tumors presented with regional nodal disease in 7% and metastatic disease (pulmonary) in 23% of the cases. Seventy-eight percent of the abdominal tumors were metastatic at diagnosis; the other 22% had extensive regional disease. In the thorax 78% had localized lesions with 22% having extensive regional disease. Ninety percent of synovial cell sarcomas were on the extremities: 84% localized disease and 12% metastatic spread at presentation. Sixty percent of the fibrosarcomas presented on the extremities with 80% having localized disease and 20% metastatic spread. Only 25% of the neurogenic tumors presented with localized disease, whereas 50% had metastases at the time of diagnosis. Because a significant percentage of nonrhabdomyosarcoma soft tissue tumors in the pediatric population present with regional and metastatic disease, incisional biopsy for diagnosis, surgical control of local disease, node sampling for accurate staging, and evaluation for metastatic spread remain crucial for maximizing outcome.

KW - Nonrhabdomyosarcoma soft tissue tumor

KW - pediatric malignancies

UR - http://www.scopus.com/inward/record.url?scp=0026508926&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026508926&partnerID=8YFLogxK

U2 - 10.1016/0022-3468(92)90320-7

DO - 10.1016/0022-3468(92)90320-7

M3 - Article

VL - 27

SP - 241

EP - 245

JO - Journal of Pediatric Surgery

JF - Journal of Pediatric Surgery

SN - 0022-3468

IS - 2

ER -